Miltefosine - Endo, Inc.
At a glance
- Drug Originator Baxter Oncology; Zentaris
- Drug Licenced by Knight Therapeutics; MegaPharm Ltd; Nimrall; Profounda
- Drug Class Antineoplastics; Antiparasitics; Phospholipids; Quaternary ammonium compounds
- Mechanism of Action Signal transduction pathway inhibitors
- USA Patent Applicants KNIGHT THERAPS
- NDAs 1
- Patent Applications 4,221
Table of Contents
Disclaimer